Dr. David R. Koos, Ph.D., DBA., has been the Chairman of the Board, Chief Executive Officer, Acting Chief Financial Officer and Secretary of Bio-Matrix Scientific Group Inc., an affiliate of Regen BioPharma Inc., since June 19, 2006. Dr. Koos has been the President of Regen BioPharma Inc. since May 29, 2013. He has been the Chief Executive Officer, President and Secretary of Entest Biomedical, Inc., since June 19, 2006 and serves as its Principal Financial Officer. Dr.
... Koos serves as Chief Executive Officer of BMSN at Entest Biomedical, Inc. He has been the Chairman of the Board, Chief Executive Officer, President, Secretary, and Acting Chief Financial Officer of Entest CA since August 22, 2008. He has been the President, Chief Executive Officer, Secretary, Chief Financial Officer and Principal Accounting Officer of JBCC since June 19, 2009. Dr. Koos has been the President and Managing Director of Venture Bridge Inc. since November 21, 2001. He is the Founder and has been President and Managing Director of Cell Source Research Inc. since December 5, 2001. He served as the Chief Financial Officer, Principal Accounting Officer and Treasurer of Entest Biomedical, Inc. from June 19, 2006 to April 2010. He served as the Principal Accounting Officer and Treasurer of Bio-Matrix Scientific Group, Inc. and served as its President since June 19, 2006 and its Chief Operating Officer June 2009. Dr. Koos served as the Chief Executive Officer, Acting Chief Financial Officer, Principal Accounting Officer, Chief Financial Officer and Secretary of Frezer Inc. from May 2005 to February 2007. He served as Secretary of Tulip BioMed Inc. until December 1, 2003. He has been involved with investment banking, venture capital, and investor relations for over 20 years. He has worked with several major Wall Street investment banks. He has an extensive involvement with Initial Public Offerings, Secondary Offerings and Private Placements, greatly benefiting Bio-Matrix Scientific Inc. Dr. Koos served as the Chairman of the Board, Chief Financial Officer and Secretary of Cell Bio-Systems Inc. from July 17, 2003 to December 1, 2003. He served as the Chief Executive Officer, Acting Chief Financial Officer and Chairman of BMXP Holdings Inc. from December 6, 2004 to June 2008 and also served as its Secretary since December 6, 2004. He served as the Chief Executive Officer, Secretary, Acting Chief Financial Officer and Chairman of BMSG since December 6, 2004. Dr. Koos served as the Chief Executive Officer and Chairman of Storage Suites America since December 2004. Dr. Koos served as Vice President of Investments at Sutro & Co., Everen Securities and Dean Witter. He served as Registered Representative of Amerivet Securities Inc. from March 31, 2004 to February 2008. He has been Chairman of Entest Biomedical, Inc. since June 19, 2006. He has been the the Chairman of the Board of Bio-Matrix Scientific Group, Inc. since June 14, 2006. Dr. Koos served as the Chairman of the Board of Frezer Inc. from May 2005 to February 2007. Dr.Koos served as the Chairman of Tasco Holdings International Inc. since July 1, 2006. He has been a Director of Entest Biomedical, Inc. since June 19, 2006. He has been a Director of JBCC since June 19, 2009. He served as a Director of Tasco Holdings International Inc. since July 1, 2006. He served as a Director of Tulip BioMed Inc. until December 1, 2003. He served as a Director of Frezer Inc. from May 2005 to February 2007. He served as a Director of BMXP Holdings Inc. He is working towards a Ph.D. in Financial Management at Northcentral University. Dr. Koos received his first doctorate is a Doctor of Philosophy degree a in Economic Sociology from the University of California Riverside in 1983. He holds a Ph.D in Economic Sociology in September 2003 and Doctor of Business Administration (DBA), with a specialization in Corporate Finance in 2003 from Atlantic International University. Dr. Koos received a Master of Arts degree in Sociology from the University of California, Riverside, California in 1983. Read More:
http://investorshangout.com/post/995850/Dr-Da...z2gO6A7nzW More on the
Stock Market 
(0)
(0)